White House Endorses 'Critical' FDA User Fee Legislation

Law360, New York (May 17, 2012, 3:15 PM EDT) -- The White House on Thursday threw its weight behind legislation reauthorizing and expanding user fees that fund U.S. Food and Drug Administration pharmaceutical reviews, labeling the bill “critical to the nation’s health.”

A bipartisan plan for renewing the fees was introduced this week in the Senate, where Majority Leader Harry Reid, D-Nev., is aiming for a vote next week.

“The administration strongly supports passage of ... the Food and Drug Administration Safety and Innovation Act, which will help speed safe and effective drugs, medical devices and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.